← Issue №17/ week of Oct 25, 2026/ the whole section, in full

Endoscopy, in full.

All 8 Endoscopy papers in this issue, as full cards, ranked by clinical utility. The issue page carries the strongest few; this is the section, whole.

Sections this issue
Filter

All 8, in full

most clinically useful first
Endoscopy prospective cohort · n=789 · Oct 20, 2026 · Eur J Gastro Hep · IF 2.2

Endoscopic retrograde cholangiopancreatography-related pancreatitis and cholangitis differ according to biliary stricture anatomy: a cohort study.

New evidenceERCPbiliary stricture
What it foundMiddle/high biliary strictures had higher rates of PEP (5% vs 1%) and cholangitis (4.7% vs 1.2%) compared to low strictures.
ContextThis literature reports that biliary stricture anatomy influences the risk of post-ERCP pancreatitis and cholangitis.
Emergingsuggested applicable standard· American Society for Gastrointestinal Endoscopy (ASGE), 'American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations' (Buxbaum JL et al., Gastrointest Endosc 2023;97(2):153-162). DOI 10.1016/j.gie.2022.10.005, PMID 36517310.

… Post-procedure, monitor for the major complications (pancreatitis, sphincterotomy bleeding, perforation, cholangitis) and manage by type, PEP by Cotton criteria with fluids/analgesia, bleeding with repeat endoscopic hemostasis, perforation by Stapfer classification with surgical consult for Type I, and cholangitis with empiric antibiotics (Tokyo Guidelines TG18) plus biliary drainage; these complication-management elements are unchanged from ESGE 2020.

From our summary of this standard, unedited — the part the paper bears on. … marks omitted text. Our wording, not the guideline's; read the source for its own text.

Our full summary of this standard

For ALL patients undergoing ERCP (average-risk and high-risk alike), give periprocedural rectal NSAID prophylaxis (100 mg indomethacin or diclofenac) unless contraindicated (e.g., recent PUD, renal insufficiency), this is now a strong recommendation for unselected patients, not just high-risk ones. For high-risk patients undergoing repeated or deep pancreatic-duct access or ampullectomy, add a prophylactic small-caliber pancreatic duct stent (3-5Fr, preferably 5Fr, 3-7cm, removed within 5-10 days), strong recommendation; for other high-risk scenarios (difficult cannulation, prior PEP, precut sphincterotomy without fistulotomy), PD stenting is a conditional recommendation when PD access is easily achieved. Aggressive periprocedural/postprocedural IV hydration with lactated Ringer's (20 mL/kg bolus, then 3 mL/kg/h for 8h) is a conditional suggestion for unselected patients (most practical for inpatients), and wire-guided cannulation is conditionally favored over contrast-guided to reduce PEP risk. The SVI trial (Elmunzer, Lancet 2024) found rectal indomethacin alone did NOT meet non-inferiority versus indomethacin+stent in high-risk patients (PEP 14.9% vs 11.3%), supporting continued use of the combination bundle in high-risk cases rather than dropping the stent. Post-procedure, monitor for the major complications (pancreatitis, sphincterotomy bleeding, perforation, cholangitis) and manage by type, PEP by Cotton criteria with fluids/analgesia, bleeding with repeat endoscopic hemostasis, perforation by Stapfer classification with surgical consult for Type I, and cholangitis with empiric antibiotics (Tokyo Guidelines TG18) plus biliary drainage; these complication-management elements are unchanged from ESGE 2020.

American Society for Gastrointestinal Endoscopy (ASGE), 'American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations' (Buxbaum JL et al., Gastrointest Endosc 2023;97(2):153-162). DOI 10.1016/j.gie.2022.10.005, PMID 36517310. · reviewed 2026-07-21 ↗
Voulgaris T … Vezakis A · European Journal of Gastroenterology & Hepatology · IF 2.2 · PubMed ↗Permalink
Endoscopy rct · n=216 · Oct 22, 2026 · Endoscopy · IF 11.8

Cold versus hot snare endoscopic mucosal resection for 10-19-mm nonpedunculated colorectal polyps: a multicenter randomized trial.

New evidencepolypectomyEMRendoscopy qualitycolorectal cancer screening
Clinical takeawayCold snare EMR is a reasonable option for 10-14 mm nonpedunculated polyps; noninferiority was not shown for 15-19 mm lesions (78.6% vs 90.9%). Expect more intraprocedural bleeding with cold snare overall (19.1% vs 3.4%), with delayed bleeding rare.
What it foundCS-EMR achieved 90.4% complete resection vs. 93.2% for HS-EMR (difference -2.7%, 95%CI -9.8 to 4.3), meeting noninferiority within a 10% margin.
ContextConfirms CS-EMR as a viable option for 10-19-mm nonpedunculated colorectal polyps, refining prior evidence by demonstrating noninferiority in a randomized trial.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Jiang Q … Wu D · Endoscopy · IF 11.8 · PubMed ↗Permalink
Endoscopy prospective cohort · n=45 · Oct 23, 2026 · J Gastro Hep · IF 3.5

Endoscopic Ultrasound-Guided Fine-Needle Biopsy for Tissue Sampling of Biliary Strictures: A Multicenter Prospective Study.

New evidencebiliary strictureEUSendoscopy quality
Clinical takeawayConsider EUS-guided FNB with an end-cutting needle for distal biliary strictures without a mass; in peri-hilar strictures sensitivity was lower (75%) and two passes gave adequate tissue in only 60%.
What it foundEUS-guided FNB with end-cutting needles achieved 93.3% sample adequacy and 91.1% diagnostic accuracy in biliary strictures without an associated pancreatic or abdominal mass, with 96.6% adequacy in distal vs. 86.6% in peri-hilar strictures. Minor bleeding occurred in 4.4% of cases.
ContextConfirms EUS-guided FNB with end-cutting needles as a viable alternative to traditional sampling methods, with higher adequacy and accuracy rates in biliary strictures without an associated pancreatic or abdominal mass.
Measured against the standard of care· ESGE 2026 (biliary stricture management; replaces ESGE 2018 stenting guideline) / ESGE 2025 (biliary stricture diagnosis)

… For distal extrahepatic strictures with no pancreatic mass, do combined same-session EUS-guided tissue acquisition plus ERCP brushing and biopsy. …

From our summary of this standard, unedited — the part the paper bears on. … marks omitted text. Our wording, not the guideline's; read the source for its own text.

Our full summary of this standard

Diagnosis is unchanged and still follows the separate ESGE diagnostic guideline (Endoscopy 2025;57:166-185). Start with MRI/MRCP plus laboratory tests, read CA19-9 only after decompression, and check IgG4 when IgG4-related sclerosing cholangitis is suspected. For distal extrahepatic strictures with no pancreatic mass, do combined same-session EUS-guided tissue acquisition plus ERCP brushing and biopsy. For perihilar strictures, sample by ERCP first and move to cholangioscopy-guided biopsy if the result is indeterminate. Do not place an uncovered SEMS (USEMS) until malignancy is confirmed. Management now follows the 2026 ESGE biliary stricture management guideline, which replaces the 2018 stenting guideline and brings it into line with the 2022 therapeutic EUS guideline. Benign: post-cholecystectomy strictures get temporary multiple plastic stents (MPSs), exchanged every 3-4 months with as many stents as possible, for about 12 months. A fully covered SEMS (FCSEMS) is an option only if the stricture is more than 2 cm below the hepatic confluence or the patient will not comply with repeated ERCPs. Anastomotic strictures after liver transplant get MPSs, or a temporary FCSEMS if more than 2 cm below the confluence. Nonanastomotic post-transplant strictures that can be treated endoscopically get MPSs plus balloon dilation if needed. Chronic pancreatitis strictures get a temporary 8-10 mm FCSEMS for 6-12 months. High-grade PSC strictures get balloon dilation alone, with no stent, because stenting adds no benefit and may add adverse events. Endotherapy is indicated for a benign stricture with liver tests raised for more than 1 month and/or cholangitis. Malignant distal: drain before surgery only selectively (cholangitis, severe jaundice or pruritus, delayed surgery). When drainage is needed before surgery or neoadjuvant therapy, or for palliation, place a 10-mm SEMS endoscopically. Endoscopic drainage is preferred over surgery or PTBD for inoperable obstruction. Malignant hilar: manage in high-volume centres with a hepatobiliary multidisciplinary team (MDT). ERCP is preferred over PTBD for preoperative drainage. Palliate Bismuth I-II with ERCP. For Bismuth III-IV, ERCP or ERCP combined with EUS-guided drainage (EUS-BD) is preferred over primary PTBD, with PTBD as a complement if needed. For proven Bismuth II-IV, aim to drain more than 50%, ideally 70% or more, of the viable nonatrophic liver volume using several routes as needed. Use plastic stents when the drainage strategy is undefined or the centre is not expert. USEMS are for expert centres when the diagnosis is proven, the tumour is unresectable, and complete drainage is predicted. After failed or unfeasible ERCP, EUS-BD is recommended over PTBD. Use hepaticogastrostomy (EUS-HGS) if there is a duodenal stricture, and EUS-HGS or choledochoduodenostomy (EUS-CDS) if there is not. PTBD is used if EUS-BD fails. In surgically altered anatomy, benign disease gets enteroscopy-assisted ERCP first; malignant disease gets enteroscopy-assisted ERCP or EUS-BD. Give antibiotics before ERCP in selected cases: predicted incomplete drainage, hilar strictures, immunocompromised patients, PSC, cholangioscopy. This follows the ESGE ERCP-adverse-events guideline. Etiology-specific care (Strasberg injuries, IgG4-SC, Mirizzi, choledochal cysts) is unchanged.

ESGE 2026 (biliary stricture management; replaces ESGE 2018 stenting guideline) / ESGE 2025 (biliary stricture diagnosis) · reviewed 2026-10-11 ↗
Facciorusso A … Crinò SF · Journal of Gastroenterology and Hepatology · IF 3.5 · PubMed ↗Permalink
Endoscopy meta analysis · n=346 · Oct 19, 2026 · GIE · IF 8.0

Meta-analysis of single session versus two-stage endoscopic ultrasound directed transgastric ERCP (EDGE) in gastric bypass patients.

New evidenceERCPEUSbariatric endoscopymeta-analysis
Clinical takeawayEither approach remains reasonable; 7 observational studies (346 patients) are too imprecise to show the two are equivalent (technical success OR 0.34, 95% CI 0.03-3.53).
What it foundSingle-session EDGE and two-stage EDGE had similar outcomes for technical success (OR 0.34, 95% CI 0.03 to 3.53), clinical success (OR 1.88, 95% CI 0.38 to 9.17), and adverse events (OR 1.45, 95% CI 0.38 to 5.48).
ContextThis meta-analysis found no significant differences in outcomes between single-session EDGE and two-stage EDGE in gastric bypass patients, suggesting comparable efficacy and safety.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Singh S … Adler DG · Gastrointestinal Endoscopy · IF 8.0 · PubMed ↗Permalink
Endoscopy prospective cohort · n=19 · Oct 21, 2026 · Endoscopy · IF 11.8

Reconstructive Endoscopic Suturing for Defect Closure After Large ≥90% Circumferential Colorectal Endoscopic Submucosal Dissection.

New evidenceESDcolorectal cancerendoscopy qualityhemostasis
Clinical takeawayA promising signal for expert ESD centres, not yet a standard: the 0/19 vs 8/15 stricture comparison is non-randomized and the non-sutured lesions were larger; the authors call for prospective multicentre validation.
What it foundReconstructive endoscopic suturing prevented symptomatic strictures in 0/19 sutured patients versus 8/15 (53.3%) non-sutured patients with large ≥90% circumferential colorectal ESD lesions.
ContextChallenges current practice: no established prophylactic strategy exists for stricture prevention in an exceptionally high-risk cohort of colorectal ESD lesions.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Aslan F … Hatipoglu A · Endoscopy · IF 11.8 · PubMed ↗Permalink
Endoscopy systematic review · Oct 22, 2026 · Endoscopy · IF 11.8

Endoscopic ultrasound in hepatology: A European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review.

Guideline / review
Clinical takeawayConsider EUS-guided techniques in hepatology and portal hypertension for specific indications (e.g., liver biopsy, gastric varices treatment) in expert centers with appropriate expertise. No clinical action yet for portal vein sampling: investigational.
What it foundEUS-guided techniques are supported for selected use in liver stiffness assessment, focal lesion characterization, liver biopsy, portal pressure gradient measurement, and gastric varices treatment, with portal vein sampling remaining investigational. Evidence is limited by small studies, heterogeneous techniques, and variable outcome definitions.
ContextRefines current practice by providing evidence-based recommendations for selective use of EUS-guided techniques, addressing variability in adoption due to technical and expertise factors. Applicable to patients with liver disease and portal hypertension in expert centers.
Emergingsuggested applicable standard· AASLD, 'Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis', Hepatology 2024 (PMID 37870298), the governing document for acute variceal hemorrhage. Baveno VII (J Hepatol 2022, PMID 35120736) is the consensus it operationalises. The prior citation, ACG 'Disorders of the Hepatic and Mesenteric Circulation' (2020), covers Budd-Chiari, portal vein thrombosis and mesenteric ischemia and does NOT address variceal bleeding, a mis-anchor, not a stale edition.

No single passage of this standard matched the paper closely enough to quote, so none is shown. The standard is cited above.

Our full summary of this standard

For acute variceal hemorrhage in cirrhosis, resuscitate conservatively with a restrictive RBC transfusion strategy targeting hemoglobin 7-8 g/dL, start a vasoactive agent as soon as bleeding is suspected and before endoscopy (terlipressin, somatostatin, or octreotide; octreotide is the agent available for this indication in US practice) and continue it 2-5 days, and give empiric IV ceftriaxone 1 g every 24 hours in patients with advanced cirrhosis. Perform upper endoscopy within 12 hours of presentation once resuscitated, or as soon as safely possible if the patient is unstable, with band ligation for esophageal varices and for GOV1 (which is treated as an esophageal varix); cardiofundal varices (GOV2 and IGV1) are treated with cyanoacrylate injection, with EUS-guided coil placement with or without cyanoacrylate increasingly used as first-line where expertise exists, and TIPS or BRTO as alternatives or salvage. PPIs started empirically should be stopped immediately after endoscopy unless there is a separate strict indication. Evaluate every patient at presentation for pre-emptive (early) TIPS with a PTFE-covered stent, placed within 72 hours and ideally within 24 hours, in high-risk patients defined as Child-Pugh class C with score under 14 (that is, 10-13) or Child-Pugh class B with score above 7 who have active bleeding at initial endoscopy despite vasoactive drugs; the decision is individualized and multidisciplinary, weighing age, frailty, comorbidity, heart failure, HCC, portal vein thrombosis, and transplant candidacy. For uncontrolled bleeding, a self-expanding covered esophageal metal stent is as effective as balloon tamponade and is the safer option; both are a bridge to definitive therapy (PTFE-covered TIPS) and neither is definitive therapy. Balloon tamponade must NOT be left in place for more than 24 hours, 24 hours is the ceiling, not a range: Baveno VI states it "should only be used in refractory oesophageal bleeding, as a temporary bridge (for a maximum of 24 h) with intensive care monitoring and considering intubation, until definitive treatment can be instituted", because severe esophageal injury/necrosis, perforation and aspiration rise sharply beyond that point. The 72-hour figure in this standard belongs to the pre-emptive TIPS window and must not be read as a permissible tamponade duration. Secondary prophylaxis is mandatory in all survivors and is combination therapy: a nonselective beta-blocker, either a traditional NSBB (propranolol or nadolol) or carvedilol, which Baveno VII endorses as an equivalent rather than clearly superior option in this specific indication, plus serial EVL every 2 to 8 weeks until variceal eradication, with surveillance endoscopy thereafter. TIPS is the treatment of choice for patients who rebleed despite NSBB plus EVL.

AASLD, 'Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis', Hepatology 2024 (PMID 37870298), the governing document for acute variceal hemorrhage. Baveno VII (J Hepatol 2022, PMID 35120736) is the consensus it operationalises. The prior citation, ACG 'Disorders of the Hepatic and Mesenteric Circulation' (2020), covers Budd-Chiari, portal vein thrombosis and mesenteric ischemia and does NOT address variceal bleeding, a mis-anchor, not a stale edition. · reviewed 2026-07-31 ↗
Fabbri C … Fuccio L · Endoscopy · IF 11.8 · PubMed ↗Permalink
Endoscopy retrospective · n=9,940 · Oct 23, 2026 · J Gastroenterology · IF 5.7

Claims-based frailty and short-term adverse events after esophageal or gastric endoscopic submucosal dissection in older adults.

New evidencehealth servicesepidemiologybiomarker
Clinical takeawayFrailty marks higher short-term ESD risk in older adults; the authors suggest claims data may help flag patients for closer peri-procedural assessment, but the score was not tested as a triage tool.
What it foundFrailty, defined by the Hospital Frailty Risk Score (HFRS) calculated from diagnoses during a 2-year lookback period, was associated with a 1.35x higher odds (95% CI 1.19-1.53) of short-term adverse events after esophageal or gastric endoscopic submucosal dissection (ESD) in patients aged ≥75 years, compared to non-frail patients. This was driven by increased rates of perforation/peritonitis and delayed bleeding, though no significant differences were observed for 30-day mortality, thromboembolic events, or aspiration pneumonia. Frailty was also associated with lower overall survival during follow-up.
ContextRefines risk stratification beyond age and comorbidity alone, suggesting claims data can flag higher-risk patients for ESD, though frailty also correlates with lower overall survival.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Hisada H … Fujishiro M · Journal of Gastroenterology · IF 5.7 · PubMed ↗Permalink
Endoscopy retrospective · n=1,077 · Oct 18, 2026 · J Gastro Hep · IF 3.5

SPEED-EMR Score: A Simple Predictive Model for Estimating Colorectal Endoscopic Mucosal Resection Duration.

New evidenceEMRcolonoscopyendoscopy quality
Clinical takeawayConsider using the SPEED-EMR Score to estimate procedure duration for colorectal EMRs, aiding in scheduling and resource allocation.
What it foundThe SPEED-EMR Score (0-15 points) predicts EMR duration with R2 = 0.445, using lesion size, flat/depressed morphology, NICE type 2 pattern, difficult anatomical location, and recurrent lesion status. It discriminates well for low-complexity (≤ 20 min; AUC: 0.77) and high-complexity (≥ 40 min; AUC: 0.75) procedures.
ContextThis tool addresses a gap in objective prediction of EMR duration, refining workflow efficiency in therapeutic endoscopy.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Souto M … Cotter J · Journal of Gastroenterology and Hepatology · IF 3.5 · PubMed ↗Permalink
← Back to issue №17 Every section of this issue is one click away, at the top of this page. Follow Endoscopy by RSS